| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 11.77%229.28 | 205.14 | 192.40 | 180.72 | 162.55 |
| Cost Of Revenue | 12.22%142.13 | 126.65 | 117.16 | 108.69 | 97.37 |
| Gross Profit | 11.04%87.15 | 78.49 | 75.24 | 72.03 | 65.18 |
10.74%92.70 | 83.71 | 84.01 | 83.09 | 75.47 | |
| Research and Development | 13.58%12.98 | 11.43 | 12.09 | 12.52 | 11.01 |
| Operating Income/Loss | 6.23%-5.55 | -5.22 | -8.78 | -11.06 | -10.29 |
| Nonoperating Income/Loss | 179.90%0.59 | 0.21 | 0.75 | -0.56 | -16.16 |
| Income/Loss From Equity Method Investments | 74.66%0.26 | 0.15 | -0.14 | 0.22 | 0.22 |
| Income/Loss From Continuing Operations Before Tax | 1.02%-4.96 | -5.01 | -8.02 | -11.61 | -26.45 |
| Income Tax Expense/Benefit | 42.74%0.35 | 0.25 | 0.61 | -0.02 | -0.01 |
1.05%-5.31 | -5.26 | -8.64 | -11.60 | -26.44 | |
| Available To Common Stockholders, Basic | 0.87%-5.31 | -5.27 | -8.63 | -11.60 | -26.43 |
| Attributable To Noncontrolling Interest | 112.50%-0.00 | 0.01 | -0.00 | - | -0.00 |